Albireo Pharma Inc
Albireo Pharma Inc logo
ALBO

Albireo Pharma Inc (ALBO)

$21.320.9%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$20.77
Day's Range
$21.39
$17.81
52-Week Range
$37.86
1 month return3.63%
3 month return40.29%
1 year return40.21%
5 year return14.18%

Company Information

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
OrganizationAlbireo Pharma Inc
CEORonald Cooper
IndustryHealth Technology

Analyst Recommendation

based on 12 analysts ratings

Buy
91%
Buy
8%
Hold
0%
Sell

Based on 12 Wall street analysts offering stock ratings for Albireo Pharma Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 264.41%

Current

$21.13

Target

$77.0

Recommendation Trend

Based on 12 analyst

Current1M Ago3M Ago
Buy
11
11
13
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
630.0M
Book Value
9.1
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.77
PEG Ratio
0.0
Wall Street Target Price
73.4

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
15.52
Price/Book (mrq)
3.66
Enterprise Value
405.2M
Enterprise Value/Revenue
9.99
Enterprise Value/Ebitda
0.0

Technicals

Beta
1.07
50 Day MA
32.04
200 Day MA
29.18

Institutional Holdings

Perceptive Advisors LLC

12.06%

Federated Hermes Inc

12.05%

BlackRock Inc

5.97%

Chicago Capital, LLC

5.17%

Vanguard Group Inc

4.99%

State Street Corporation

4.64%

Discover more

Frequently Asked Questions

What is Albireo Pharma Inc share price today?

Can Indians buy Albireo Pharma Inc shares?

How can I buy Albireo Pharma Inc shares from India?

Can Fractional shares of Albireo Pharma Inc be purchased?

What are the documents required to start investing in Albireo Pharma Inc stocks?

What are today’s High and Low prices of Albireo Pharma Inc?

What are today’s traded volumes of Albireo Pharma Inc?

What is today’s market capitalisation of Albireo Pharma Inc?

What is the 52 Week High and Low Range of Albireo Pharma Inc?

How much percentage Albireo Pharma Inc is down from its 52 Week High?

How much percentage Albireo Pharma Inc is up from its 52 Week low?

What are the historical returns of Albireo Pharma Inc?

Who is the Chief Executive Officer (CEO) of Albireo Pharma Inc?